Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Cash flows from operating activities:    
Net income $ 33,449 $ 29,640
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,428 5,393
(Gain)Loss on disposal of assets 155 324
Gain on investment in business 0 (528)
Deferred Income Tax Expense (Benefit) 53 (23)
Allowance for doubtful accounts 29 8
Stock-based compensation expense 2,744 2,124
(Increase) decrease in, net of assets acquired:    
Accounts receivable (2,850) (4,514)
Inventories 204 (151)
Income taxes receivable 954 728
Other current assets (1,185) (525)
Other assets 146 284
Increase (decrease) in, net of liabilities assumed:    
Accounts payable 1,289 1,115
Accrued expenses and other liabilities 2,949 2,206
Income taxes payable 2,329 679
Other noncurrent liabilities 3 21
Net cash provided by operating activities 46,697 36,781
Payments to Acquire Businesses, Net of Cash Acquired 0 923
Cash flows from investing activities:    
Capital expenditures (6,953) (14,569)
Proceeds from Sale of Productive Assets 6 70
Purchases of short-term investments (42,788) (22,945)
Proceeds from sale of short-term investments 25,396 19,327
Net cash used in investing activities (24,339) (19,040)
Cash flows from financing activities:    
Proceeds from stock issued 623 651
Dividends to shareholders (9,509) (7,072)
Change in restricted cash (3) 1
Net cash used in financing activities (8,889) (6,420)
Effect of exchange rate changes on cash and cash equivalents (2,286) 691
Net increase (decrease) in cash and cash equivalents 11,183 12,012
Cash and cash equivalents, beginning of period 54,912 34,478
Cash and cash equivalents, end of period 66,095  
Cash paid:    
Income taxes 13,818 13,440
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities 3,226 3,486
Common stock issued for deferred director’s compensation through other noncurrent liabilities $ 0 $ 294